These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 35856502

  • 1. Hepatic arterial infusion oxaliplatin plus raltitrexed and chemoembolization in hepatocellular carcinoma with portal vein invasion: A propensity score-matching cohort study.
    Chen S, Yuan B, Yu W, Wang X, He C, Chen C.
    J Surg Oncol; 2022 Dec; 126(7):1205-1214. PubMed ID: 35856502
    [Abstract] [Full Text] [Related]

  • 2. Comparison of Arterial Infusion Chemotherapy and Chemoembolization for Locally Advanced Hepatocellular Carcinoma: a Multicenter Retrospective Study.
    Chen S, Yuan B, Yu W, Wang X, He C, Chen C.
    J Gastrointest Surg; 2022 Nov; 26(11):2292-2300. PubMed ID: 35920966
    [Abstract] [Full Text] [Related]

  • 3. Combination Therapy of Chemoembolization and Hepatic Arterial Infusion Chemotherapy in Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis Compared with Chemoembolization Alone: A Propensity Score-Matched Analysis.
    Liu BJ, Gao S, Zhu X, Guo JH, Kou FX, Liu SX, Zhang X, Wang XD, Cao G, Chen H, Liu P, Zhu LZ, Xu HF, Yang RJ.
    Biomed Res Int; 2021 Nov; 2021():6670367. PubMed ID: 34337041
    [Abstract] [Full Text] [Related]

  • 4. Hepatic Arterial Infusion Chemotherapy Using Oxaliplatin Plus 5-Fluorouracil Versus Transarterial Chemoembolization/Embolization for the Treatment of Advanced Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombosis.
    Hu J, Bao Q, Cao G, Zhu X, Yang R, Ji X, Xu L, Zheng K, Li W, Xing B, Wang X.
    Cardiovasc Intervent Radiol; 2020 Jul; 43(7):996-1005. PubMed ID: 31974744
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of transcatheter arterial chemoembolization plus hepatic arterial infusion chemotherapy in the treatment of advanced hepatocellular carcinoma with portal vein tumor thrombosis in the main trunk.
    Wu Z, Gao J, Zhuang W, Yang J, Guo W.
    J Cancer Res Ther; 2022 Apr; 18(2):345-351. PubMed ID: 35645099
    [Abstract] [Full Text] [Related]

  • 6. Hepatic artery infusion chemotherapy combined with camrelizumab plus rivoceranib for hepatocellular carcinoma with portal vein tumor thrombosis: a multicenter propensity score-matching analysis.
    Li Y, Guo J, Liu W, Pang H, Song Y, Wu S, Zhang F, Yan D, Chen J, An C, Li C.
    Hepatol Int; 2024 Aug; 18(4):1286-1298. PubMed ID: 38717693
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of hepatic arterial infusion chemotherapy in patients with primary liver cancer with portal vein tumor thrombosis: a comparative analysis of different perfusion chemotherapeutic regimens.
    Tu X, Zhang W, Li S, He Q, Li Y.
    Eur J Med Res; 2024 Sep 19; 29(1):465. PubMed ID: 39294739
    [Abstract] [Full Text] [Related]

  • 8. Lenvatinib plus drug-eluting bead transarterial chemoembolization with/without hepatic arterial infusion chemotherapy for hepatocellular carcinoma larger than 7 cm with major portal vein tumor thrombosis: a multicenter retrospective cohort study.
    Cai M, Liang L, Zhang J, Chen N, Huang W, Guo Y, Hong X, Lin L, Liu Y, Dan C, Deng H, Liu X, Zhou J, Chen Y, Chen H, Zhu K.
    Int J Surg; 2024 Jun 13; 110(12):7860-70. PubMed ID: 38869974
    [Abstract] [Full Text] [Related]

  • 9. Hepatic Arterial Infusion Chemotherapy with Oxaliplatin Plus Raltitrexed as an Alternative Option in Advanced Hepatocellular Carcinoma Patients with Failure of, or Unsuitability for, Transarterial Chemoembolization.
    Wu Y, Zheng S, Zhang Z, Chen G, Chen X, Zheng T, Guo X, Chen H, Wang M, Xie X, Zhang B.
    Medicina (Kaunas); 2022 Sep 24; 58(10):. PubMed ID: 36295504
    [Abstract] [Full Text] [Related]

  • 10. TACE-HAIC combined with targeted therapy and immunotherapy versus TACE alone for hepatocellular carcinoma with portal vein tumour thrombus: a propensity score matching study.
    Yuan Y, He W, Yang Z, Qiu J, Huang Z, Shi Y, Lin Z, Zheng Y, Chen M, Lau WY, Li B, Yuan Y.
    Int J Surg; 2023 May 01; 109(5):1222-1230. PubMed ID: 37026861
    [Abstract] [Full Text] [Related]

  • 11. Gamma knife radiosurgery versus transcatheter arterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a propensity score matching study.
    Su K, Gu T, Xu K, Wang J, Liao H, Li X, Wen L, Song Y, Zhong J, He B, Liu X, He J, Liu Y, Li Q, Feng X, Chen S, Yang B, Huang W, Jin H, Luo X, Hu T, Chen J, Wu Z, Lu S, Zhang J, Rao M, Xie Y, Wang J, Zhu X, Chen L, Li B, Su S, Yang X, Wang J, Zeng H, Wang P, Yan M, Chen X, He K, Han Y.
    Hepatol Int; 2022 Aug 01; 16(4):858-867. PubMed ID: 35729469
    [Abstract] [Full Text] [Related]

  • 12. Induction therapy with hepatic arterial infusion chemotherapy enhances the efficacy of lenvatinib and pd1 inhibitors in treating hepatocellular carcinoma patients with portal vein tumor thrombosis.
    Fu Y, Peng W, Zhang W, Yang Z, Hu Z, Pang Y, Hu D, Chen J, Wang J, Zhou Z, Xu L, Chen M, Zhang Y.
    J Gastroenterol; 2023 Apr 01; 58(4):413-424. PubMed ID: 36894804
    [Abstract] [Full Text] [Related]

  • 13. Hepatic Artery Infusion Chemotherapy Using Fluorouracil, Leucovorin, and Oxaliplatin versus Transarterial Chemoembolization as Initial Treatment for Locally Advanced Hepatocellular Carcinoma: A Propensity Score-Matching Analysis.
    Li S, Lyu N, Han X, Li J, Lai J, He M, Deng H, Shi M, Wang H, Zhao M.
    J Vasc Interv Radiol; 2021 Sep 01; 32(9):1267-1276.e1. PubMed ID: 34166806
    [Abstract] [Full Text] [Related]

  • 14. Tyrosine kinase inhibitors, immune checkpoint inhibitors combined with hepatic arterial infusion of oxaliplatin and raltitrexed versus oxaliplatin, 5-fluorouracil and leucovorin for intermediate and advanced hepatocellular carcinoma: A retrospective study.
    Zang M, Hu X, Yuan G, Li R, Li W, Pang H, Li Q, Chen J.
    Int Immunopharmacol; 2023 Dec 01; 125(Pt A):111019. PubMed ID: 37879230
    [Abstract] [Full Text] [Related]

  • 15. Sorafenib Plus Hepatic Arterial Infusion Chemotherapy versus Sorafenib for Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombosis: A Randomized Trial.
    Zheng K, Zhu X, Fu S, Cao G, Li WQ, Xu L, Chen H, Wu D, Yang R, Wang K, Liu W, Wang H, Bao Q, Liu M, Hao C, Shen L, Xing B, Wang X.
    Radiology; 2022 May 01; 303(2):455-464. PubMed ID: 35103539
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of transcatheter arterial chemoembolization combined with either 125I seed implantation or apatinib in hepatocellular carcinoma with portal vein tumor thrombosis: A retrospective comparative study.
    Li Y, Li H, Hu H, Yuan H, Zhao Y.
    J Cancer Res Ther; 2020 May 01; 16(7):1691-1697. PubMed ID: 33565518
    [Abstract] [Full Text] [Related]

  • 17. Efficiency and safety of hepatic arterial infusion chemotherapy (HAIC) combined with anti-PD1 therapy versus HAIC monotherapy for advanced hepatocellular carcinoma: A multicenter propensity score matching analysis.
    Li Y, Liu W, Chen J, Chen Y, Guo J, Pang H, Zhang W, An C, Li C.
    Cancer Med; 2024 Jan 01; 13(1):e6836. PubMed ID: 38196277
    [Abstract] [Full Text] [Related]

  • 18. Transarterial Chemoembolization Combined With Apatinib Plus PD-1 Inhibitors for Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Multicenter Retrospective Study.
    Xia WL, Zhao XH, Guo Y, Hu HT, Cao GS, Li Z, Fan WJ, Xu SJ, Li HL.
    Clin Transl Gastroenterol; 2023 May 01; 14(5):e00581. PubMed ID: 36920551
    [Abstract] [Full Text] [Related]

  • 19. Transarterial embolization and low-dose continuous hepatic arterial infusion chemotherapy with oxaliplatin and raltitrexed for hepatocellular carcinoma with major portal vein tumor thrombus.
    Zhu LZ, Xu S, Qian HL.
    World J Gastroenterol; 2018 Jun 21; 24(23):2501-2507. PubMed ID: 29930471
    [Abstract] [Full Text] [Related]

  • 20. Hepatic artery infusion chemotherapy using mFOLFOX versus transarterial chemoembolization for massive unresectable hepatocellular carcinoma: a prospective non-randomized study.
    He MK, Le Y, Li QJ, Yu ZS, Li SH, Wei W, Guo RP, Shi M.
    Chin J Cancer; 2017 Oct 23; 36(1):83. PubMed ID: 29061175
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.